Science Corporation Secures $230 Million Series C for Advanced Brain-Computer Interface Development

Science Corporation, founded by Max Hodak, has completed a Series C funding round, raising $230 million. The company is developing biohybrid brain-computer interface technology and has already conducted human trials for its PRIMA implant, which has restored eyesight. Hodak is scheduled to speak at TechCrunch Disrupt 2026 about the potential end of the screen era and new forms of human-machine interaction.

Science Corporation successfully raised $230 million in its Series C funding round, achieving a valuation of $1.5 billion.

Max Hodak, co-founder and CEO of Science Corporation, has a background in biomedical engineering from Duke Pratt School of Engineering and worked in a brain-computer interface lab. He previously co-founded Transcriptic, a robotic cloud laboratory, and was a co-founder and initial president of Neuralink in 2016. He established Science Corporation in 2021 to focus on advanced neural engineering.

Science Corporation's work aims to revolutionise human-machine interaction by moving beyond traditional screens, proposing interfaces that adapt to users through brain-computer interactions. Their technology, such as the PRIMA implant, has demonstrated success in restoring vision for individuals with severe sight loss. The company also envisions broader applications for its brain-implanted sensors, including healing damaged brain cells, seizure warnings, and potentially treating conditions like Parkinson’s disease.

Max Hodak will present his vision for a post-screen technological future at the "Beyond Screens" session on the Disrupt Stage at TechCrunch Disrupt 2026 in San Francisco. His insights will offer a perspective on how brain-computer interfaces could reshape technology and daily life.